Chips Charging Ahead, Pills Slipping Behind

Tech stocks are roaring back on a U.S.-China tariff agreement, but pharma stocks are sinking after news of U.S. drug price cuts. Meanwhile, a tiny healthcare firm is soaring 400% on a bold crypto pivot. Here’s everything you need to get up to speed!

Smart Moves (Sponsored)

Tired of Hype-Driven Investing? Here's a Smarter Alternative

Most people are chasing meme coins, TikTok crypto tips, or whatever the latest "wealth hack" is.

But one full-time investor quietly found something else—something real—that’s outperforming even Apple and Nvidia.

It’s not on the stock exchange. It's not flashy. But it's backed by billion-dollar industries and quietly traded in a hidden market like stocks.

He put together a free report to show exactly how it works — no pitch, no hype, just something most investors never see.

[Read the Free Report] – Skip the noise. See what actually works.

*Disclaimer: All individual claims are independent views, and the result may vary as per potential & caliber
(from person to person). Results may not be typical nor expected for every person. This is not a "get rich quick" scheme. All information provided on this website and webinar is based on best practices and for educational-purposes only. We are publishers, not licensed financial advisors. Information provided is for informational purposes only and is not intended as financial advice. Always consult a professional advisor for personalized financial guidance.

Futures 📈

What to Watch

Earnings:

• Simon Property Group, Inc. [SPG]: Aftermarket

• Archer Aviation Inc. [ACHR]: Aftermarket

• DaVita Inc. [DVA]: Aftermarket

• StandardAero, Inc. [SARO]: Aftermarket

• NuScale Power Corporation [SMR]: Aftermarket

Economic Reports:

• Fed Governor Adriana Kugler speech: 10:25 AM

• Monthly U.S. federal budget [April]: 2:00 PM

Private Power (Sponsored)

Billion-Dollar Industries You’re Not Watching—But Should Be

This isn’t a meme stock or viral crypto tip—it’s a real asset quietly outperforming tech giants.

Built on massive industries and traded outside the spotlight, this strategy delivers without the drama.

One full-time investor shares the details in this free report—no hype, no hard sell.

Most never hear about it. This is the chance to change that.

[Read the Free Report] – Discover what drives long-term, quiet growth.

*Disclaimer: All individual claims are independent views, and the result may vary as per potential & caliber
(from person to person). Results may not be typical nor expected for every person. This is not a "get rich quick" scheme. All information provided on this website and webinar is based on best practices and for educational-purposes only. We are publishers, not licensed financial advisors. Information provided is for informational purposes only and is not intended as financial advice. Always consult a professional advisor for personalized financial guidance.

Technology

Nvidia, Apple, Amazon Surge as Trade Tensions Ease

A breakthrough in trade talks between the U.S. and China is sending global tech and semiconductor stocks sharply higher in premarket today morning.

Companies with heavy exposure to Chinese manufacturing and supply chains—such as Apple (NASDAQ: AAPL) and Amazon (NASDAQ: AMZN)—are leading the rally, with Apple jumping over 6% and Amazon up more than 8% in premarket trading.

Apple had previously warned that tariffs could add $900 million to its quarterly costs due to its reliance on Chinese production.

Semiconductor firms are among the biggest gainers. Nvidia (NASDAQ: NVDA) is up roughly 4%, AMD (NASDAQ: AMD) and Broadcom (NASDAQ: AVGO) are each up 6%, and Marvell Technology (NASDAQ: MRVL) is surging 8%.

Qualcomm (NASDAQ: QCOM) and Taiwan Semiconductor Manufacturing Company (NYSE: TSM) are also seeing strong gains.

European chip suppliers like ASML (NASDAQ: ASML) and Infineon Technologies (OTCMKTS: IFNNY) are also climbing on hopes of reduced trade friction.

U.S.-listed Chinese tech stocks, including Alibaba (NYSE: BABA), JD.com (NASDAQ: JD), and Baidu (NASDAQ: BIDU), are also up amid optimism that the easing of tariffs could restore smoother trade flows.

Pharmaceuticals

Pharma Stocks Slide Globally as Trump Renews Push to Cut U.S. Drug Prices

Pharmaceutical stocks are down sharply in premarket trade after U.S. President Donald Trump announced plans to issue an executive order that would cut domestic drug prices, sparking investor fears over shrinking profits across the industry.

Trump intends to sign the order at 9 a.m. in Washington, aiming to align U.S. drug prices with those in the world’s lowest-cost countries.

Shares of major U.S. drugmakers including Pfizer (NYSE: PFE) (-2%) , Eli Lilly (NYSE: LLY) (-3.3%), Merck (NYSE: MRK) (-2.3%), and Bristol-Myers Squibb (NYSE: BMY) (-0.7%) are all trading lower premarket.

European firms such as AstraZeneca (LSE: AZN), Roche, Novo Nordisk, and Sanofi are also down, despite broader market gains. Japan’s Topix pharmaceutical index recorded its steepest one-day loss since August.

Companies heavily reliant on U.S. revenue—such as Takeda, Astellas, and Otsuka—are especially exposed. For many European firms, the U.S. accounts for 40% to 60% of total sales.

While Trump has previously attempted similar reforms, prior efforts were blocked in court.

Still, with Medicare and Medicaid comprising roughly 40% of U.S. drug spending, even a limited executive order could have "enormous" revenue implications.

No Noise (Sponsored)

Outperforming Tech, Without The Volatility

While others chase hype and headlines, one investor uncovered a private-market opportunity outperforming Apple and Nvidia.

It’s not traded on any major exchange. But it’s tied to billion-dollar industries—and backed by real assets.

This free report breaks it down with no gimmicks or sales pitch—just the facts.

The market is real. The upside could be massive.

[Read the Free Report] – Skip the noise. See what actually works.

*Disclaimer: All individual claims are independent views, and the result may vary as per potential & caliber
(from person to person). Results may not be typical nor expected for every person. This is not a "get rich quick" scheme. All information provided on this website and webinar is based on best practices and for educational-purposes only. We are publishers, not licensed financial advisors. Information provided is for informational purposes only and is not intended as financial advice. Always consult a professional advisor for personalized financial guidance.

Furniture

Wayfair, RH Lead Rally After Major Tariff Rollback Agreement

Shares of U.S. furniture and home improvement retailers are soaring in premarket trading Monday after the U.S. and China agreed to a 90-day suspension of steep tariffs, offering relief to companies with significant exposure to Chinese imports.

Under the new agreement, the U.S. will slash tariffs on Chinese goods from 145% to 30%, while China will lower its duties from 125% to 10%.

The announcement has marked a significant easing of trade tensions between the two largest global economies.

Retailers with direct supply chain links to China are leading the surge. Wayfair (NYSE: W) is up 15.3%, RH (formerly Restoration Hardware [NYSE: RH]) 17.93%, and Williams-Sonoma (NYSE: WSM) 5.4%.

Home improvement giants Home Depot (NYSE: HD) and Lowe’s (NYSE: LOW) are also gaining, rising 3.2% and nearly 3.5%, respectively.

The rally comes after a challenging year for many in the sector. As of last close, Wayfair had declined 28% year-to-date, RH was down nearly 51%, and Williams-Sonoma had shed 14.5%.

Meanwhile, Home Depot and Lowe’s shares had slipped 6.6% and 10%, respectively.

Kindly MD, Inc. [KDLY] - Last Close: $3.90

Kindly MD is a healthcare provider. The firm had a 28% revenue decline and a net loss of $3.62 million last year, but despite this, its stock is up over 200% this year.

Today the stock is surging 400%+ in premarket trade is due to a merger with Nakamoto Holdings, introducing a Bitcoin treasury strategy backed by a $510-million private placement and $200 million in convertible notes.

Gryphon Digital Mining, Inc [GRYP] - Last Close: $1.31

Gryphon Digital Mining, Inc., is a bitcoin miner. Its stock is surging over 330% in premarket today after announcing a merger with Eric Trump-backed American Bitcoin. The merger makes Gryphon a major player in the crypto space.

CytomX Therapeutics, Inc. [CTMX] - Last Close: $0.93

CytomX Therapeutics is a clinical-stage biopharma. Its done well on both revenue and profitability fronts in the last two year.

It’s rising 52% in premarket today due to positive interim results from its Phase 1 trial of CX-2051, an antibody-drug conjugate for advanced colorectal cancer.

Quiet Alpha (Sponsored)

The Asset Class Wall Street Ignores

A little-known market is quietly delivering stronger returns than some of the hottest stocks.

It’s not in crypto, not in real estate, and not in traditional equities.

This hidden corner of the financial world is attracting serious capital—and outperforming big tech.

This free report shows how it works, and why most investors miss it.

[Access the Report Now] – Get the facts before this market goes mainstream.

*Disclaimer: All individual claims are independent views, and the result may vary as per potential & caliber
(from person to person). Results may not be typical nor expected for every person. This is not a "get rich quick" scheme. All information provided on this website and webinar is based on best practices and for educational-purposes only. We are publishers, not licensed financial advisors. Information provided is for informational purposes only and is not intended as financial advice. Always consult a professional advisor for personalized financial guidance.

Everything Else

• Ceasefire sparks investor optimism across Indian and Pakistani exchanges.

• CATL eyes global growth with a $4B listing amid U.S. scrutiny and market pressure.

• Quantum Machines raised $100 million to expand its global presence in the quantum computing industry.

• As lights go out across Spain and Portugal, questions rise over energy security, not just green goals.

• South Korea vows action after Washington’s tariff hike targets tech and pharma exports.

• LTIMindtree lands a $450 million contract as the Indian tech sector shows signs of revival.

• Polestar's efforts to streamline its business and sell more vehicles helped shrink its losses.

That’s all for today. Thank you for reading. If you have any feedback, please reply to this email.

Best Regards,

— Adam Garcia
Elite Trade Club

Click here to get our daily newsletter straight to your cell for free.

P.S. Just like this newsletter, it's 100% free*, and you can stop at any time by replying STOP.

*Standard message/carrier rates may apply.

Legal Stuff: Stocks featured in this newsletter are for entertainment purposes only. You should not base any investment decisions on information contained in my newsletter. Stocks featured in this newsletter may be owned by owners/operators of this website, which could impact our ability to remain unbiased. Please consult a financial advisor before making any trading decisions. I may earn a small commission from links placed inside these emails.